Expression of matrix metalloproteinase-9 (gelatinase B) in benign, premalignant and malignant laryngeal lesions

Histology and Histopathology

Volumn 21, Issue 4-6, 2006, Pages 603-608

  Peschos, D ^a   Damala, C ^a   Stefanou, D ^a   Tsanou, E ^a   Assimakopoulos, D ^a   Vougiouklakis, T ^a   Charalabopoulos, K ^a   Agnantis, N J ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Laryngeal cancer; Laryngeal lesions; Matrix metalloproteinases 9

Indexed keywords

GELATINASE B;

ADULT; AGE; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER SURVIVAL; CARCINOMA IN SITU; CONTROLLED STUDY; DISEASE CLASSIFICATION; DYSPLASIA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATOSIS; LARYNX CANCER; LARYNX PAPILLOMATOSIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SQUAMOUS CELL CARCINOMA; TUMOR VOLUME; UPREGULATION;

CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATOSIS; LARYNGEAL DISEASES; LARYNGEAL NEOPLASMS; LARYNX; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEOPLASM INVASIVENESS; PAPILLOMA; PRECANCEROUS CONDITIONS; UP-REGULATION;

EID: 33645573336     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Behrens P., Mathiak M., Mangold E., Kirdorf S., Wellmann A., Fogt F., Rothe M., Florin A. and Wernert N. (2003). Stromal expression of invasion-promoting, matrix-degrading proteases MMP-1 and -9 and the Ets 1 transcription factor in HNPCC carcinomas and sporadic colorectal cancers. Int. J. Cancer 107, 183-188.
2. Bogusiewicz M., Stryjecka-Zimmer M., Szymanski M., Rechberger T. and Golabek W. (2003). Activity of matrix metalloproteinases-2 and -9 in advanced laryngeal cancer. Otolaryngol. Head Neck Surg. 128, 132-136.
3. Brenner C.A., Adler R.R., Rappolee D.A., Pedersen R.A. and Werb Z. (1989). Genes for extracellular matrix degrading MMP and their inhibitor TIMP are expressed during early mammalian development. Genes Dev. 3 848-859.
4. Campo E., Tavassoli F.A., Charonis A.S., Stetler-Stevenson W.G., Liotta L.A. and Merino M.J. (1992). Evaluation of basement membrane components and the 72 Kda type IV collagenase in serous tumors of the ovary. Am. J. Pathol. 6, 500-507
5. Coussens L.M. and Werb Z. (1996). Matrix metalloproteinases and the development of cancer. Chem. Biol. 3, 895-904.
6. Delaisse J.M. and Vaes G. (1992). Mechanism of mineral solublization and matrix degradation in osteoclastic bone resorption. In: Biology and physiology of the osteoclast. Rifkin B.R. and Gay C.V. (eds). CRC Press Inc. Philadelphia. pp 397-441.
7. Di Nezza L., Misajon A., Zhang J., Jobling T., Quinn M.A., Ostor A.G. Nie G., Lopata A. and Salamonsen L.A. (2002). Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion. Cancer 94, 1466-1475.
8. Franchi A., Santucci M., Masini E., Sardi I., Paglierani M. and Gallo O. (2002). Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neck. Cancer 95, 1902-1910.
9. Friedmann R., Toth M., Pena D. and Mobashery S. (1995). Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2). Cancer Res. 55, 2548-2555.
10. Garzetti G.G., Ciavattini A., Lucarini G., Goteri G., Romani C. and Biagini G. (1996). Microinvasive cervical carcinoma and cervical intraepithelial neoplasia: Biologic significance and clinical implications of 72 kDa metalloproteinase immunnostaining. Gynecol. Oncol. 61, 197-203.
11. Goldberg G., Frisch S., He C., Wilhelm S., Reich F. and Collier I. (1990). Secreted proteases. Regulation of their activity and their possible role in metastasis. Ann. NY Acad. Sci. 580, 375-384.
12. Grevin D., Chen J.H., Raes M., Stehelin D., Vandenbunder B. and Desbiens X. (1993). Involvement of the proto-oncogene c-ets 1 and the urokinase plasminogen activator during mouse implantation and placentation. Int. J. Dev. Biol. 37, 519-529.
13. Iwasaka C., Tanaka K., Abe M. and Sato Y. (1996). Ets-1 regulates angiogenesis by inducing the expression of urokinase-type plasminogen activator and matrix metalloproteinase-1 and the migration of vascular endothelial cells. J. Cellular Physiol. 169, 522-531.
14. Jones L., Ghaneh P., Humphreys M. and Neoptolemos J.P. (1999). The matrix metalloproteinases and their inhibitors in the treatment of pancreatic cancer. Ann. NY. Acad. Sci. 880, 288-307.
15. Kleiner D.E. and Stetler-Stevenson W.G. (1994). Quantitative zymography: detection of picogram quantities of gelatinases. Ann. Biochem. 218, 325-329.
16. Krecicki T., Zalesska-Krecicka M., Jelen M., Szkudlarek T. and Horobiowska M. (2001). Expression of type IV collagen and matrix metalloproteinase-2 (type IV collagenase) in relation to nodal status in laryngeal cancer. Clin. Otolaryngol. 26, 469-472.
17. Leblond C.P. and Inoue S. (1989). Structure, composition and assembly of basement membrane. Am. J. Anat. 185, 367-390
18. Magary S.P., Ryan M.W., Tarnuzzer R.W. and Kornberg L. (2000). Expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in laryngeal and pharyngeal squamous cell carcinoma: A quantitative analysis. Otolaryngol. Head Neck Surg. 122, 712-716
19. Mc Cawley L.J. and Matrisian L.M. (2000). Matrix metalloproteinases: multifunctional contributors to tumor progression. Mol. Med. Today 6, 149-156.
20. Murphy G.J.P., Murphy G. and Reynolds J.J. (1991). The origin of matrix metalloproteinases and their familial relationships. FEBS Lett, 289, 4-7.
21. Murray G.I., Duncan M.E., Arbuckle E., Melvin W.T. and Fothergill J.E. (1998). Matrix metalloproteinases and their inhibitors in gastric cancer. Gut 43, 791-797.
22. Nelson A.R., Fingleton B., Rothenberg M.L. and Matrisian L.M. (2000). Matrix metalloproteinases: biologic activity and clinical implications. J. Clin. Oncol. 18:5 (18): 1135-1149.
23. Nethery A. and O'Grady R.L. (1989). Identification of a metalloproteinase co-purifying with rat tumor collagenase and the characteristics of fragments of both enzymes. Biochim. Biophys. Acta 994, 149-160.
24. Rabbani S. and Xing R. (1998). Role of urokinase (uPA) and its receptor (UPAR) in invasion and metastasis of hormone-dependent malignancies. Int. J. Oncol. 12, 911-920.
25. Sarioglu S., Ozer E., Kirimca F., Sis B. and Pabuccuoglu U. (2001). Matrix metalloproteinase-2 expression in laryngeal preneoplastic and neoplastic lesions. Pathol. Res. Pract. 197, 483-486.
26. Schmitt M., Janicke F., Moniwa N., Chucholowski N., Pache L. and Graeff H. (1992). Tumor-associated urokinase-type plasminogen activator: biological and clinical significance. Biol. Chem. Hoppe Seyler 373, 611-622.
27. Senior R.M., Griffin G.L., Fliszar C.J., Shapiro S.D., Goldberg G.I. and Welgus H.G. (1991). Human 92- and 72-kilodalton type IV collagenases are elastases. J. Biol. Chem. 266, 7870-7875.
28. Sun Y., Wenger L., Rutter J.L., Brinckerhoff C.E. and Cheung H.S. (1999). P53 down-regulates human matrix metalloproteinase-1 (collagenase-1) gene expression. J. Biol. Chem. 274, 11535-11540.
29. Sun Y., Cheung J.M. and Martel-Pelletier J. (2000). Wild type and mutant p53 differentially regulate the gene expression of human collagenase-3 (hMMP-13). J. Biol. Chem. 275, 11327-11332.
30. Sutinen M., Kaunilainen T., Hurskainen T., Kameyema T. and Morimatsu M. (1998). Expression of matrix metalloproteinases (MMP 1-2) and their inhibitors (TIMP-1,-2,-3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastases. Br. J. Cancer 77, 2239-2245.
31. Talvensaari-Mattila A., Apaja-Sakkinen M., Hoythya M., Westurland A., Puistula U. and Turpeennuemi-Hujanen T. (1999). Matrix metalloproteinase 2 immunoreactive protein appears early in cervical epithelial differentiation. Gynecol. Oncol. 72, 306-311.
32. Wasylyk C., Gutman A., Nicholson R. and Wasylyk B. (1991). The c-Ets oncoprotein activates the stromelysin promoter through the same elements as several non-nuclear oncoproteins. EMBO J. 10, 1127-1134.
33. Watabe T., Yoshida K., Shindoh M., Kaya M., Fujikawa K., Sato H., Ishii S. and Fujinaga K. (1998). The Ets-1 and Ets-2 transcription factors activate the promoters for invasion-associated urokinase and collagenase genes in response to epidermal growth factor. Int. J. Cancer 77, 128-137.
34. Westermarck J. and Kahari V-M. (1999). Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J. 13, 781-792.
35. Wolf C., Chenard M.P., de Grossouvre P.D., Bellocq J.P., Chambon P. and Basset P. (1992). Breast-cancer associated stromelysin-3 gene is expressed in basal cell carcinoma and during cutaneous wound healing. J. Invest. Dermatol. 99, 870-872.
36. Zeng Z.S., Cohen A.M. and Guillem J.G. (1999). Loss of basement membrane type IV collagen is associated with increased expression of metalloproteinases 2 and 9 (MMP-2 and MMP-9) during colorectal carcinogenesis. Carcinogenesis 20, 749-755.